Gene Therapy for X-Linked Retinitis Pigmentosa (IMAGE)
Caption
Using gene therapy to augment normal levels of the RPGR gene resulted in long-term rescue of photoreceptors within the retinal region of gene therapy injection, but not within the control injection. The rescue lasted at least 2.5 years when the disease was treated in its later stages.
Credit
University of Pennsylvania
Usage Restrictions
In context of reporting
License
Licensed content